Home›Research›Compare›Davunetide vs Met-Enkephalin
Peptide ComparisonDavunetide vs Met-Enkephalin
Both are Neuro & Cognitive peptides.
Met-Enkephalin
Methionine enkephalin
5 providers listed
Davunetide carries stronger published evidence (RCT, 3 key studies) than Met-Enkephalin (Cohort study, 4); both are research compounds.
Davunetide
Evidence
Met-Enkephalin
Evidence
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Davunetide |
| Further along in FDA review | Davunetide |
| More provider options (0 vs 5) | Met-Enkephalin |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Davunetide
Met-Enkephalin
Davunetide
Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…
Met-Enkephalin
Endogenous opioid peptides in trichotillomania: An exploratory analysis of focused and automatic hair-pulling…
Unraveling the role of iodide in photosensitized oxidation of Met-Enkephalin.
Duration of opioid receptor blockade determines biotherapeutic response
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and…
About Davunetide
Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.
About Met-Enkephalin
Binds OGF receptors (zeta opioid receptors) on cell nuclei, regulating DNA synthesis and cell proliferation in a tonic inhibitory manner. Also binds delta opioid receptors. Intermittent blockade by low-dose naltrexone upregulates receptor expression and endogenous MENK tone.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Davunetide
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Met-Enkephalin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Where to source these peptides
Davunetide
Browse directory →
Providers offeringMet-Enkephalin
5 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Neuro & Cognitive Comparisons
Browse all peptides →Educational research tools — not medical advice.